Skip to main content
OpenTrials

Clinical trial condition

Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS)

Explore clinical trials studying Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) trial results

Recruiting

Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

NCT06465953

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Presbyterian / St. Luke'S Medical Center Denver, Colorado, United States
  • University of Chicago, Duchossois Center for Advanced Medicine (DCAM) Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • MSKCC New York, United States
View all 62 locations
View Trial Details

Related conditions